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Objectives.Determinetherelationshipbetweendepressivesymptomclustersandneuropsychologicaltestperformanceinanelderly
cohort of cognitively normal controls and mild Alzheimer’s disease (AD). Design. Cross-sectional analysis. Setting. Four health
science centers in Texas. Participants. 628 elderly individuals (272 diagnosed with mild AD and 356 controls) from ongoing
longitudinal study of Alzheimer’s disease. Measurements. Standard battery of neuropsychological tests and the 30-item Geriatric
Depression Scale with regressions model generated on GDS-30 subscale scores (dysphoria, apathy, meaninglessness and cognitive
impairment) as predictors and neuropsychological tests as outcome variables. Follow-up analyses by gender were conducted.
Results. For AD, all symptom clusters were related to speciﬁc neurocognitive domains; among controls apathy and cognitive
impairment were signiﬁcantly related to neuropsychological functioning. The relationship between performance and symptom
clusters was signiﬁcantly diﬀerent for males and females in each group. Conclusion. Findings suggest the need to examine disease
status and gender when considering the impact of depressive symptoms on cognition.
1.Introduction
A number of studies have reported an association between
depressive symptoms and cognitive dysfunction in the eld-
erly [1–3]withscoresondepressionscalesbeing signiﬁcantly
related to speciﬁc neurocognitive domains of visuospatial
skills, executive functioning, psychomotor speed, as well as
memory [4–6]. Depressed but cognitively normal elderly
subjects often diﬀer in their performance on neuropsycho-
logical tests from Alzheimer’s disease (AD) patients [7].
Speciﬁc patterns of performance on neuropsychological tests
have been found to diﬀerentiate depression from AD [8].
However, little research has examined the potential impact
of speciﬁc depressive symptoms or symptom clusters on
detailed neuropsychological functioning.
The majority of research examining the neurocognitive
consequences of depression has utilized total scores on
depression scales, groupings based on cutoﬀ scores on a
rating scale, or diagnosis of a depressive disorder based on
a variety of criteria (e.g., DSM-IV-TR). However, symptom
clusters as well as depressive endophenotypes have been well
documented to have clinical relevance. Furthermore, the
treatment of depression as a unitary concept obscures the
link betweenspeciﬁcareasofcognitive functioning andthese
depressive symptom clusters. The limited research that has
beenconductedwithdepressivesymptomclustershasshown
that speciﬁc symptoms diﬀerentially relate to performance
on neuropsychological tests. Janzing and colleagues [9]
studying a sample of 60 demented subjects used a principal
components analysis to derive a motivation factor and2 Depression Research and Treatment
amoodfactorfromtheDSM-IIIcriteriafordepression.They
found that the motivation factor was related to performance
on measures of verbal ﬂuency while the mood factor and
general depressive symptoms did not relate to performance
on any neuropsychological test. Castro-Costa and colleagues
[10] in a study of a large European sample of elders from ten
countries in the SHARE sample found that the motivation
factor score of the EURO-D depressive screening scale was
signiﬁcantly related to poorer performance on a measure
of verbal ﬂuency but not to verbal memory. The affective
suﬀering factor was not signiﬁcantly related to any neu-
ropsychological test scores. O’Bryant and colleagues [11]e x -
amined data from 184 participants of Project FRONTIER,
an ongoing epidemiological study of rural health, and found
that depressive symptom clusters were speciﬁcally associated
with neuropsychological domains. In that study, depressive
feelingsofdysphoria,meaninglessness,andcognitiveimpair-
ment were signiﬁcantly associated with memory, language,
and attention domains; however, the pattern of signiﬁcance
varied when the sample was split by gender and ethnicity.
As these studies show, subtypes of depressive symptoms
are diﬀerentially related to speciﬁc neurocognitive domains.
However, this question has not been investigated in a sample
of elderly patients with or without Alzheimer’s disease.
The present study investigated the relationship between
the four clusters of depressive symptoms of the GDS iden-
t i ﬁ e db yH a l la n dD a v i s[ 12] and performance on a standard
battery of neuropsychological tests in a cohort of cognitively
intact elderly and elderly diagnosed with mild Alzheimer’s
disease (AD). It was hypothesized that depressive symptoms
and neuropsychological testing would interact diﬀerentially
among cognitively normal elderly compared to elderly
subjects with AD. Previous research [11] on the subscales has
shown signiﬁcant diﬀerences between males and females in
their endorsement patterns and impact on neuropsycholog-
ical test scores in a nondemented ethnically diverse sample.
Therefore, it was also hypothesized that males and females
in both the cognitively normal group and AD group would
exhibit distinct patterns of relationships between symptom
clusters and neuropsychological functioning.
2. Methods
2.1. Participants. Participants included 628 individuals (272
diagnosed with probable AD and 356 cognitively intact)
enrolled in the longitudinal research cohort of the Texas
Alzheimer’s Research Consortium (TARC), a well-charac-
terized representative cohort of AD and normal controls as-
sessed annually. The methodology of the TARC project
has been described in detail elsewhere [13]. Brieﬂy, each
participant undergoes an annual evaluation that includes a
medical examination, interview, neuropsychological testing,
and blood draw. AD patients met consensus-based diagnosis
for probable AD based on NINCDS-ADRDA criteria [14]
and scored 0.5 or 1.0 on the CDR global score. Controls
performedwithinnormallimitsonpsychometricassessment
and were assigned a CDR global score of 0.0. The breakdown
of the CDR global scores was as follows: 0 = 356 (controls),
0.5 = 71 (AD), and 1.0 = 201 (AD). The vast majority
of participants were Caucasian (93%). The characteristics
of the participants are presented in Table 1.T h eT A R C
project received Institutional Review Board approval and
all participants and/or caregivers signed written informed
consent documents.
2.2.Measures. TheTARCneuropsychologycorebatterycon-
sisted of commonly utilized instruments including Wechsler
digit span, Trail Making Test, Wechsler Logical Memory,
Wechsler Visual Reproduction, Boston Naming Test (30-
and 60-item versions), verbal ﬂuency (FAS), the Geriatric
Depression Scale (GDS-30), and the Clinical Dementia Rat-
ing scale (CDR). In order to equate scores from digit span
and story memory scales across test versions, all raw scores
were converted to scale scores based on previously published
normative data. For the Boston Naming Test, the authors
recently conducted an independent study that demonstrated
the psychometric properties of an estimated 60-item BNT
score that is calculated from 30-item versions [15]. Scale
scores adjusted for age and education were utilized as
dependent variables in analyses.
Geriatric Depression Scale (GDS) Subscales. The Geriatric
Depression Scale [16] was the ﬁrst depression scale pri-
marily used as a screening instrument designed for older
populations and has been used widely in clinical settings
and research with the elderly. However, the GDS was
not speciﬁcally designed for use with cognitively impaired
elderly. The vast majority of studies using the GDS have
employed total score or a clinical cutoﬀ.Ar e c e n tf a c t o r
study [12] on older individuals with cognitive impairment
identiﬁed four factors of the GDS which the authors
describe as (1) dysphoria factor, (2) meaninglessness factor,
(3) apathy factor, and (4) Cognitive Impairment factor.
The Dysphoria factor contains 11 items primarily associated
with a sad mood. The Meaninglessness factor consists of
seven items that reﬂect an appraisal of the meaning (or
lack thereof) in one’s life. The apathy factor is made up of
six items that reﬂect a lack of motivation or initiative. The
cognitive impairment factor consists of six items that reﬂect
diﬃculty and concern with cognitive processes. The GDS
subscale scores were utilized as predictor variables. Although
these subscales were developed using a mixed sample of
cognitive disorders, they have been found to be useful when
investigating the relationship between neuropsychological
test performance and depression in nondemented samples
[11].
2.2.1. Analysis. Stepwise linear regression models were gen-
eratedforcontrolsandADsubjectswithGDSsubscalescores
entered as predictor variables and the neuropsychological
test scores entered as outcome variables, with age, gender,
and education entered as covariates. Follow-up regression
models were generated for males and females in each group.
Signiﬁcance for analyses was set at P<. 05. Adjusted scale
scores were used for Digit Span, Logical Memory I and II,Depression Research and Treatment 3
Table 1: Descriptive statistics (means and standard deviations) for participants.
Alzheimer’s disease All (N = 272) Male (N = 100) Female (N = 172)
Age 77.06 (8.413) 75.70 (8.012) 77.68 (8.359)
Education 14.44 (4.758) 15.11 (3.158) 13.98 (5.802)
Dysphoria 1.78 (2.199) 1.87 (2.292) 1.76 (2.182)
Meaninglessness .75 (1.203) .66 (1.194) .80 (1.173)
Apathy 1.38 (1.310) 1.49 (1.339) 1.39 (1.315)
Cognitive impairment 2.00 (1.507) 2.17 (1.569) 2.01 (1.438)
Verbal ﬂuency 6.78 (3.109) 6.84 (3.214) 6.76 (2.954)
Boston Naming 6.19 (3.487) 5.69 (3.311) 6.59 (3.482)
Trails A 5.78 (3.027) 6.22 (2.554) 5.57 (3.243)
Trails B 5.01 (3.061) 5.77 (3.110) 4.56 (2.955)
Digit Span 8.34 (2.568) 8.85 (2.358) 8.20 (4.56)
Logical Memory I 4.11 (2.570) 4.78 (2.744) 3.85 (2.416)
Logical Memory II 4.17 (2.072) 4.72 (2.450) 3.90 (1.812)
Visual Reproduction I 4.36 (2.450) 5.29 (2.420) 4.13 (2.321)
Visual Reproduction II 5.60 (1.857) 6.12 (2.340) 5.32 (1.526)
Controls All (N = 356) Male (N = 114) Female (N = 242)
Age 71.53 (8.566) 73.40 (8.266) 70.46 (8.559)
Education 15.64 (4.100) 16.45 (2.791) 15.17 (4.623)
Dysphoria .74 (1.431) .82 (1.361) .78 (1.464)
Meaninglessness .37 (.884) .35 (.838) .37 (.906)
Apathy .96 (1.180) .78 (1.006) 1.05 (1.245)
Cognitive impairment 1.00 (1.162) .93 (1.119) 1.03 (1.182)
Verbal ﬂuency 11.40 (3.005) 11.27 (3.235) 11.46 (2.095)
Boston Naming 12.11 (2.988) 13.13 (2.928) 11.63 (2.900)
Trails A 10.55 (2.636) 10.68 (2.918) 10.50 (2.500)
Trails B 11.01 (2.484) 10.90 (2.370) 11.06 (2.538)
Digit Span 11.31 (2.638) 11.64 (3.056) 11.16 (2.418)
Logical Memory I 13.01 (3.026) 12.53 (3.171) 13.23 (2.936)
Logical Memory II 13.65 (2.693) 12.96 (2.845) 13.98 (2.559)
Visual Reproduction I 12.20 (3.012) 12.25 (3.222) 12.17 (2.920)
Visual Reproduction II 13.47 (3.202) 13.57 (3.013) 13.43 (3.289)
Visual Reproduction I & II, Trails A & B, FAS, and Boston
Naming.
3. Results
The controls were signiﬁcantly younger and more educated
than the AD group (P ≤ .001). No signiﬁcant diﬀerences
were found between males and females within either group
on age or education (P ≥ .0 5 ) .M u l t i v a r i a t ea n a l y s i so f
variance found no signiﬁcant diﬀerences between AD males
and females on any of the subscales (P ≥ .05). There were
no signiﬁcant diﬀerences between males and females on any
of the subscales for the control group (P ≥ .05; see Table 1
for means and standard deviations).
Table 2 presents the outcomes of the regression analyses
for the control group. As shown, none of the depressive
symptom subscales were signiﬁcantly related to verbal ﬂu-
ency, Boston Naming, or Digit Span. However, the cognitive
Impairmentsubscalewassigniﬁcantlyassociatedwithpoorer
scores on Trails B as well as immediate and delayed memory
for verbal and visual information. The apathy subscale was
negatively associated with scores on Trails A.
When examined by gender, there were no signiﬁcant
ﬁndings for control males. However, for female Controls at
least one of the GDS subscales was a signiﬁcant negative
predictor for all the neuropsychological measures except
the Boston Naming Test and Digit Span (Table 2). Cogni-
tive impairment was the most robust predictor of poor per-
formance being signiﬁcantly negatively related to Trails B,
Logical Memory I, Logical Memory II, Visual Reproduction
I, and Visual Reproduction II. The meaninglessness subscale
signiﬁcantly negatively predicted verbal ﬂuency while apathy
negatively predicted Trails A scores.
Table 3 presents the stepwise regression models gen-
erated for the AD sample. None of the subscales were
signiﬁcantly related to performance on Boston Naming or
WMS Visual Reproduction I and II. Dysphoria subscale
scores were signiﬁcantly related to poorer scores on Verbal
Fluency, Trails A, Trails B, and Digit Span for the total
sample of AD patients. Apathy was signiﬁcantly related4 Depression Research and Treatment
Table 2: GDS subscales and neuropsychological tests for control group by gender∗.
Test
Control N = 356
Males N = 114 Females N = 242
Standardized coeﬃcient Standardized coeﬃcient
Scale β TP Scale β TP
Verbal ﬂuency NS NS MLN −.158 −2.541 .012
Boston Naming NS NS NS
Trails A Apathy −.182 −3.462 .001 NS Apathy −.196 −3.105 .002
Trails B Cl −.258 −4.989 .001 NS CI −.322 −5.266 .001
Digit Span NS NS NS
Logical Memory I Cl −.197 −3.785 .001 NS CI −.257 −4.118 .001
Logical Memory II Cl −.178 −3.395 .001 NS CI −.243 −3.875 .001
Visual Reproduction I Cl −.166 −2.929 .004 NS CI −.198 −2.917 .004
Visual Reproduction II Cl −.192 −3.401 .001 NS CI −.226 −3.351 .001
∗Covariates entered into the equation age and education.
NS = no subscales signiﬁcant; DYS = dysphoria subscale; Apathy = apathy subscale; MLN = meaninglessness subscale; Cl = cognitive impairment subscale.
Table 3: GDS subscales and neuropsychological tests for Alzheimer’s group by gender∗.
Test
AD N = 272
Males N = 100 Females N = 172
Standardized coeﬃcient Standardized coeﬃcient
Scale β TP Scale β TP
Verbal ﬂuency DYS −.143 −2.277 .024 NS Apathy −.197 −2.541 .004
Boston Naming NS NS NS
Trails A DYS −.186 −2.791 .001 NS Apathy −.196 −3.105 .002
Trails B DYS −.279 −2.383 .018 CI .222 2.031 .046
DYS −.219 −2.402 −.037
Digit Span DYS .131 −1.915 .050 DYS −.329 −3.255 .002
NS
Logical Memory I Apathy −.197 −3.132 .002 NS NS
Logical Memory II Cl .183 2.953 .001 NS CI −.243 −3.875 .001
Apathy −.209 −3.356 .001
MLN −.228 −3.646 .001
Visual Reproduction I NS NS Apathy −.197 −2.589 .004
Visual Reproduction II NS NS Apathy −.200 −2.007 .048
∗Covariates entered into the equation age and education.
NS = no subscales signiﬁcant; DYS = dysphoria subscale; Apathy = apathy subscale; MLN = meaninglessness subscale; Cl = cognitive Impairment subscale.
to poorer immediate and delayed verbal memory (WMS
Logical Memory I and II) while the meaninglessness subscale
scores were negatively related to delayed verbal recall (WMS
Logical Memory II). The cognitive impairment subscale was
signiﬁcantly and positively related to measures of delayed
recall of verbal information. Analyses broken down by
gender (Table 3)a g a i nr e v e a l e dad i ﬀerent picture than was
observed from analyses conducted with the total sample.
AmongwomendiagnosedwithAD,scoresonVerbalFluency,
Logical Memory II, and Visual Reproduction I were signiﬁ-
cantly negatively related to the Apathy subscale. Trails A and
Bwerebothaﬀectednegativelybythedysphoriasubscale.For
AD males, Trails B was negatively associated with the cog-
nitive impairment subscale while Digit Span was negatively
associatedwithdysphoria. Nootherneuropsychological tests
had a signiﬁcant relationship to depressive symptom clusters
for AD males.
4. Discussion
The current ﬁndings suggest that the link between depres-
sion and cognitive functioning is quite complex. These
results demonstrate that speciﬁc clusters of depressive symp-
toms and disease status, as well as gender can diﬀeren-
tially impact neuropsychological domains. These ﬁndings
point to the need to speciﬁcally examine disease status and
gender when considering the eﬀect of depressive symptoms
on neuropsychological functioning as these relationships are
obscured in the overall models when simply covarying for
these factors.Depression Research and Treatment 5
This is further illustrated by our examination of the rela-
tionship between symptom clusters and neuropsychological
performance by case status (Alzheimer’s disease or normal
controls). Among patients diagnosed with AD, the GDS-
30 subfactors of dysphoria and apathy were the factors
most consistently associated neuropsychological testing. Ele-
vationsindysphoriaandapathywererelatedtopoorerscores
inattentionandexecutivefunctioningandverbalﬂuencyand
memory, respectively. It is interesting to note that among
AD cases scores on the cognitive impairment subscale were
signiﬁcantly associated with better scores on delayed mem-
ory (visual and verbal) among the total sample. However,
when the sample was split by gender, a diﬀerent picture was
observed as the vast majority of the ﬁndings were held only
forwomen,whichisconsistentwithourearlierﬁndings[11].
The cognitively normal controls presented a very diﬀer-
ent pattern of relationships between subfactors and cogni-
tion. In this sample, the subfactor of cognitive impairment
was, by far, the most robust predictor of neuropsychological
test performance. However, as with the AD sample, a dif-
ferent proﬁle was seen when broken down by gender such
that the link between depressive subfactors and cognitive
status only held for women.
These ﬁndings point to the need to directly examine
cohorts by demographic factors rather than covarying for
them when considering the complex impact depression has
on health status. Our ﬁndings suggest that the link between
depression and neuropsychological functioning is most
relevantforwomen,particularlyamongthosewithoutaneu-
rodegenerative disorder. Rosenberg and colleagues [17]i na
longitudinal study of cognitively healthy older women used
total GDS score and found a strong relationship between
number of depressive symptoms and decline in a number
of cognitive domains. In our study we found that the
speciﬁc depressive symptom cluster related to concern with
cognitive status was signiﬁcantly related to poorer cognitive
performance in cognitively normal older women. These
ﬁndings directly contradict the old adage “if they present
with complaints of cognitive dysfunction they are likely
depressed” and suggest that such a notion may potentially
prevent women who have real cognitive disturbances from
receiving appropriate attention.
Our ﬁndings also demonstrate that the meaning of de-
pressive symptoms changes once an individual has been di-
agnosed with a neurodegenerative dementia syndrome, such
as Alzheimer’s disease. Among Alzheimer’s disease cases, it
is feelings of apathy and dysphoria that are most important.
These ﬁndings are not surprising given the wealth of the
literature documenting social withdrawal and isolation as
an early sign (or consequence) of AD. However, given
that social withdrawal is also a symptom of depression,
it is important that elders presenting with these speciﬁc
symptoms of depression be referred for a comprehensive de-
mentia examination so that treatment can be implemented
early in the course of the disease when treatments are
most efﬁcacious.
The generalizability of our ﬁndings is limited by the
nature of the sample. The study is cross-sectional and
the TARC cohort at this time is predominately Caucasian,
relatively well-educated, and, for the most part, urban.
Our sample was limited to mild AD which does not
allow us to evaluate the aﬀect of these symptoms as the
disease progresses. Additionally individuals with high levels
ofdepressioninitiallyorwithadiagnosisofmajordepression
are excluded from the cohort. It is therefore diﬃcult to
determine the impact of level of depression. As can be
seen from Table 1, the overall level of depressive symptoms
is relatively low for both AD and controls. Even with the low
number of depressive symptoms endorsed there is still a dif-
ferential impact of symptom clusters on neuropsychological
domains. The subscales used in this research were originally
developed through factor analysis of a sample of individuals
with a variety of cognitive disorders. The application of these
scales to a cognitively normal sample may be a limitation
although previous research on cognitively intact elderly [11]
using the subscales has shown their utility in describing the
relationship of depressive symptom clusters to neuropsycho-
logical performance. Additionally the role that education
may play in moderating the relationship between depressive
symptoms and neuropsychological performance was not
directly investigated. It is likely that the eﬀect of education
was controlled to at least some extent through the use of
education-adjusted neuropsychological scales scores and the
ﬁnding that education did not signiﬁcantly impact any of the
relationships reported.
A potential implication for the current ﬁndings is on rate
of progression. Given the current ﬁndings of a diﬀerential
link between speciﬁc depressive symptoms and cognitive
functioningbetweenADcasesandcontrols,itispossiblethat
the depressive symptoms most important for conveying risk
of cognitive decline over time will vary. This is of critical im-
portanceasthecurrentinvestigatorsareunawareofanyprior
work examining if speciﬁc symptoms (or symptom clusters)
of depression are most important in predicting decline over
time or if these “depressive risk symptoms” diﬀer by case or
controls status. That is, are speciﬁc symptoms of depression
related to the risk for developing Alzheimer’s disease in
the future and are a diﬀerent set of depressive symptoms
important for rate of decline once the disease has become
clinically manifest?
The current ﬁndings may suggest a better understanding
of the neurobiological consequences of AD. While there
has been a wealth of literature documenting alterations in
inﬂammatory and other neurochemical pathways in both
AD and depression, no prior research has examined if the
speciﬁc symptoms of depression are diﬀerentially related
to these pathways. If speciﬁc symptoms of depression (i.e.,
apathy and dysphoria) are speciﬁcally related to modiﬁable
pathways (e.g., oxidative stress, inﬂammation), a novel ﬁeld
of targeted therapeutics for AD would be identiﬁed based on
these ﬁndings. Given that the behavioral manifestations are
themostsigniﬁcantcauseofcaregiverburdeninAD,thisline
of inquiry holds great promise.
Acknowledgment
This paper was made possible by the Texas Alzheimer’s
Research Consortium (TARC) funded by the state of Texas6 Depression Research and Treatment
through the Texas Council on Alzheimer’s Disease and
Related Disorders.
Conﬂict of Interests
The authors declare no conﬂict of interests. Including em-
ployment or aﬃliation, grants or funds, honoraria, speaker
forum,beingaconsultant,stocks,royalties,experttestimony,
being a board member, patents, or personal relationship.
Author’s Contributions
J. R. Hall designed the study, participated in the analysis of
data, and preparation of the paper; S. E. O’Bryant assisted in
the design, analysis of data, and participated in preparation
of the paper; L. A. Johnson and R. C. Barber assisted in the
analysis and preparation of the paper. The sponsor had no
role.
References
[ 1 ] V .M .Do t s o n ,S .M .R e s n i c k ,a n dA .B .Z o n d e rm a n ,“ Diﬀeren-
tial association of concurrent, baseline, and average depressive
symptoms with cognitive decline in older adults,” American
Journal of Geriatric Psychiatry, vol. 16, no. 4, pp. 318–330,
2008.
[2] J. Chodosh, D. M. Kado, T. E. Seeman, and A. S. Karlamangla,
“Depressive symptoms as a predictor of cognitive decline:
macarthur studies of successful aging,” American Journal of
Geriatric Psychiatry, vol. 15, no. 5, pp. 406–415, 2007.
[ 3 ]R .S .W i l s o n ,C .F .M e n d e sD eL e o n ,D .A .B e n n e t t ,J .L .B i -
enias, and D. A. Evans, “Depressive symptoms and cognitive
decline in a community population of older persons,” Journal
of Neurology, Neurosurgery and Psychiatry,v o l .7 5 ,n o .1 ,p p .
126–129, 2004.
[4] K. B. Boone, I. M. Lesser, B. L. Miller et al., “Cognitive
functioning in older depressed outpatients: relationship of
presence and severity of depression to neuropsychological test
scores,” Neuropsychology, vol. 9, no. 3, pp. 390–398, 1995.
[5] B. W. Palmer, K. B. Boone, I. M. Lesser, M. A. Wohl, N.
Berman, and B. L. Miller, “Neuropsychological deﬁcits among
older depressed patients with predominantly psychological or
vegetative symptoms,” Journal of Aﬀective Disorders, vol. 41,
no. 1, pp. 17–24, 1996.
[6] A. H. Kizilbash, R. D. Vanderploeg, and G. Curtiss, “The
eﬀects of depression and anxiety on memory performance,”
Archives of Clinical Neuropsychology, vol. 17, no. 1, pp. 57–67,
2002.
[7] S. L. Wright and C. Persad, “Distinguishing between depres-
sion and dementia in older persons: neuropsychological and
neuropathological correlates,” Journal of Geriatric Psychiatry
and Neurology, vol. 20, no. 4, pp. 189–198, 2007.
[ 8 ]S .F .C r o w ea n dK .H o o g e n r a a d ,“ D i ﬀerentiation of dementia
of the Alzheimer’s type from depression with cognitive
impairmentonthebasisofacorticalversussubcorticalpattern
of cognitive deﬁcit,” Archives of Clinical Neuropsychology, vol.
15, no. 1, pp. 9–19, 2000.
[9] J. G. Janzing, P. Naarding, and P. A. Eling, “Depressive
symptom quality and neuropsychological performance in de-
mentia,” International Journal of Geriatric Psychiatry, vol. 20,
no. 5, pp. 479–484, 2005.
[10] E. Castro-Costa, M. Dewey, R. Stewart et al., “Prevalence
of depressive symptoms and syndromes in later life in ten
European countries: the SHARE study,” British Journal of
Psychiatry, vol. 191, pp. 393–401, 2007.
[11] S. E. O’Bryant, J. R. Hall, K. C. Cukrowicz et al., “The diﬀer-
ential impact ofdepressive symptom clusters on cognition ina
rural multi-ethnic cohort: a project FRONTIER studyThe dif-
ferential impact of depressive symptom clusters on cognition
in a rural multi-ethnic cohort: a project FRONTIER study,”
International Journal of Geriatric Psychiatry,v o l .2 6 ,n o .2 ,p p .
199–205, 2011.
[12] J. R. Hall and T. E. Davis, “Factor structure of the geriatric
depression scale in cognitively impaired older adults,” Clinical
Gerontologist, vol. 33, no. 1, pp. 39–48, 2010.
[13] S. Waring, S. E. O’Bryant, J. S. Reisch et al., “The Texas
Alzheimer’sresearchconsortiumlongitudinalresearchcohort:
study design and baseline characteristics,” Texas Public Health
Journal, vol. 60, pp. 9–13, 2008.
[14] G. McKhann, D. Drachman, and M. Folstein, “Clinical di-
agnosisofAlzheimer’sdisease:reportoftheNINCDS-ADRDA
work group under the auspices of department of health and
human services task force on Alzheimer’s disease,” Neurology,
vol. 34, no. 7, pp. 939–944, 1984.
[15] V. L. Hobson, J. R. Hall, M. Harvey et al., “The Boston naming
test: calculation and utilization of an “estimated” 60-item
test from 15- and 30-item versions,” International Journal of
Geriatric Psychiatry, vol. 26, no. 4, pp. 351–355, 2011.
[16] J. A. Yesavage, T. L. Brink, T. L. Rose et al., “Development
and validation of a geriatric depression screening scale: a
preliminaryreport,”JournalofPsychiatricResearch,vol.17,no.
1, pp. 37–49, 1982.
[17] P. B. Rosenberg, M. M. Mielke, Q. -L. Xue, and M. C.
Carlson, “Depressive symptoms predict incident cognitive
impairment in cognitive healthy older women,” American
Journal of Geriatric Psychiatry, vol. 18, no. 3, pp. 204–211,
2010.